Publicacións en colaboración con investigadores/as de AstraZeneca (United Kingdom) (17)

2024

  1. Burden of Uncontrolled Severe Asthma With and Without Elevated Type-2 Inflammatory Biomarkers

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 12, Núm. 4, pp. 970-982

2023

  1. Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811

  2. Comparative effectiveness of anti-IL5 and anti-IgE biologic classes in patients with severe asthma eligible for both

    Allergy: European Journal of Allergy and Clinical Immunology, Vol. 78, Núm. 7, pp. 1934-1948

  3. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2732-2747

  4. Validation of the Asthma Impairment and Risk Questionnaire in Spain: A Useful Tool for Assessing Asthma Control in Adolescents and Adults

    Journal of Investigational Allergology and Clinical Immunology

2022

  1. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 10, Núm. 5, pp. 1202-1216.e23

  2. Patient perspectives of the influence of severe and non-severe asthma on their quality of life: A national survey of asthma patients in Spain

    Clinical Respiratory Journal, Vol. 16, Núm. 2, pp. 130-141

  3. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

    Journal of Asthma and Allergy, Vol. 15, pp. 63-78

2021

  1. Asthma Phenotyping in Primary Care: Applying the International Severe Asthma Registry Eosinophil Phenotype Algorithm Across All Asthma Severities

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 12, pp. 4353-4370

  2. Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 9, Núm. 7, pp. 2680-2688.e7

  3. Eosinophilic and Noneosinophilic Asthma: An Expert Consensus Framework to Characterize Phenotypes in a Global Real-Life Severe Asthma Cohort

    Chest

2020

  1. International severe asthma registry (ISAR): Protocol for a global registry

    BMC Medical Research Methodology, Vol. 20, Núm. 1

2019

  1. Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study

    Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 2, pp. 578-588.e2

  2. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    The Lancet Respiratory Medicine, Vol. 7, Núm. 1, pp. 46-59

2016

  1. Prevalence and Perception of 24-Hour Symptom Patterns in Patients With Stable Chronic Obstructive Pulmonary Disease in Spain

    Archivos de Bronconeumologia, Vol. 52, Núm. 6, pp. 308-315

2012

  1. Factors associated with health-related quality of life in adults with asthma. A cross-sectional study

    Multidisciplinary Respiratory Medicine, Vol. 7, Núm. 5

2010

  1. Factors associated with asthma control in primary care patients: The CHAS study

    Archivos de Bronconeumologia, Vol. 46, Núm. 7, pp. 358-363